Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target th...
Saved in:
| Published in: | eLife Vol. 8 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
eLife Science Publications, Ltd
23.07.2019
eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
| Subjects: | |
| ISSN: | 2050-084X, 2050-084X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, that is Myr-HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP-mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by 111In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles. |
|---|---|
| AbstractList | Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, that is Myr-HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP-mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by 111In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles. Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, that is Myr-HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP-mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by 111In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles.Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, that is Myr-HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP-mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by 111In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles. Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, that is Myr-HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP-mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by .sup.111In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles. Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; ) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, that is Myr-HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP-mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles. |
| Audience | Academic |
| Author | Kaufman, Christina Grossen, Philip Buck, Jonas Witzigmann, Dominik Schenk, Susanne H Ni, Yi Hussner, Janine Uhl, Philipp Québatte, Gabriela Meyer zu Schwabedissen, Henriette E Mier, Walter Sieber, Sandro Huwyler, Jörg Urban, Stephan Einfalt, Tomaz Schöneweis, Katrin |
| Author_xml | – sequence: 1 givenname: Dominik orcidid: 0000-0002-8197-8558 surname: Witzigmann fullname: Witzigmann, Dominik organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada – sequence: 2 givenname: Philipp surname: Uhl fullname: Uhl, Philipp organization: Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany – sequence: 3 givenname: Sandro surname: Sieber fullname: Sieber, Sandro organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 4 givenname: Christina surname: Kaufman fullname: Kaufman, Christina organization: Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany, Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, INF, Heidelberg, Germany – sequence: 5 givenname: Tomaz surname: Einfalt fullname: Einfalt, Tomaz organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 6 givenname: Katrin surname: Schöneweis fullname: Schöneweis, Katrin organization: Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, INF, Heidelberg, Germany – sequence: 7 givenname: Philip orcidid: 0000-0002-3416-5570 surname: Grossen fullname: Grossen, Philip organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 8 givenname: Jonas surname: Buck fullname: Buck, Jonas organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 9 givenname: Yi surname: Ni fullname: Ni, Yi organization: Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, INF, Heidelberg, Germany – sequence: 10 givenname: Susanne H surname: Schenk fullname: Schenk, Susanne H organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 11 givenname: Janine surname: Hussner fullname: Hussner, Janine organization: Division of Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 12 givenname: Henriette E orcidid: 0000-0003-0458-4579 surname: Meyer zu Schwabedissen fullname: Meyer zu Schwabedissen, Henriette E organization: Division of Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 13 givenname: Gabriela surname: Québatte fullname: Québatte, Gabriela organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland – sequence: 14 givenname: Walter surname: Mier fullname: Mier, Walter organization: Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany – sequence: 15 givenname: Stephan surname: Urban fullname: Urban, Stephan organization: Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, INF, Heidelberg, Germany – sequence: 16 givenname: Jörg orcidid: 0000-0003-1748-5676 surname: Huwyler fullname: Huwyler, Jörg organization: Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31333191$$D View this record in MEDLINE/PubMed |
| BookMark | eNptktuL1DAYxYusuOu6T75LwRdFOiZpc-mLsCxeBgYWvIBvIc2lk6FNapKq419vdmZWd5ZtHxrS3znJdzhPixPnnS6K5xAsKMbNW72yRi8ahCh5VJwhgEEFWPP95M76tLiIcQPyQxvGYPukOK1hXdewhWfFr-sp2dH-Ecl6V3XbSuloe1d6U671JJJPwU9WloOdrCqdcH4SIVk56FgmEXqdrOvLtNZl9MrOY5XEHLxc-0EkXcosFy5OPuywyQ_bSecDlX5WPDZiiPri8D0vvn14__XqU7W6_ri8ulxVElOSKqpYh7q2paypTasExLo1StCONgQoo6ARkDCFiTaw6wiCysAW4xZkAuDa1OfFcu-rvNjwKdhRhC33wvLdhg89P8zDAaEUGSZbY7qmMbjDEiBIITFMCIVI9nq395rmbtRKapenG45Mj_84u-a9_8kJYagBMBu8OhgE_2PWMfHRRqmHQTjt58gRIgzTmrQgoy_voRs_B5ejyhRDORBKm_9UL_IA1pmbvOWNKb_ELWF1AwHL1OIBKr9Kj1bmPhmb948Er48EmUn6d-rFHCNffvl8zL64G8q_NG4rlgG4B2TwMQZtuLRpV7d8CztwCPhNk_muyXzX5Kx5c09za_sQ_Rd2t_ZX |
| CitedBy_id | crossref_primary_10_1038_s42003_023_04859_2 crossref_primary_10_3389_fbioe_2021_701504 crossref_primary_10_1002_smll_202008198 crossref_primary_10_1080_10717544_2022_2122635 crossref_primary_10_3390_cancers12102837 crossref_primary_10_1016_j_scitotenv_2024_172240 crossref_primary_10_1038_s41467_020_17360_9 crossref_primary_10_1016_j_cotox_2022_100346 crossref_primary_10_1002_adhm_202401888 crossref_primary_10_3390_ph15020159 crossref_primary_10_2147_IJN_S349426 crossref_primary_10_1016_j_semcancer_2021_06_021 crossref_primary_10_1080_08982104_2024_2377085 crossref_primary_10_1016_j_gastha_2023_08_012 crossref_primary_10_1186_s43556_023_00160_0 crossref_primary_10_1016_j_ijpharm_2024_124381 crossref_primary_10_1016_j_drudis_2020_12_017 |
| Cites_doi | 10.1016/j.addr.2019.01.001 10.1128/JVI.00867-09 10.1016/j.ejps.2017.07.013 10.1016/j.jhep.2016.04.016 10.1039/C4NR04730C 10.1016/j.jconrel.2015.06.012 10.1016/S0168-3659(00)00293-5 10.1016/j.bbamem.2004.10.013 10.3748/wjg.v22.i38.8489 10.1039/C5RA13967H 10.1038/gt.2008.60 10.1038/nbt.2614 10.1039/C5NR07289A 10.1016/j.ejps.2010.07.015 10.3748/wjg.v13.i1.22 10.1053/j.gastro.2014.04.030 10.1021/acsnano.8b00141 10.1038/mt.2009.36 10.1021/acsnano.7b06995 10.1016/j.jconrel.2017.09.037 10.1016/j.biomaterials.2010.06.031 10.1016/j.jhep.2016.04.013 10.1007/978-3-319-30654-4_13 10.1016/j.jhep.2011.05.039 10.2147/IJN.S49770 10.1021/acsnano.8b01516 10.1016/j.virol.2016.06.024 10.7554/eLife.00049 10.3390/molecules15074773 10.1016/j.jcma.2017.02.010 10.1002/adfm.201701418 10.2174/138920012798356934 10.1021/acs.bioconjchem.6b00057 10.1016/0005-2736(90)90091-2 10.1002/hep.28013 10.1053/j.gastro.2013.12.024 10.1517/17425247.2011.554818 10.1021/acsami.5b01684 10.1186/1476-5926-1-1 10.1021/nn2000756 10.1016/j.biomaterials.2014.04.037 10.1016/j.jconrel.2017.08.023 10.1016/j.jconrel.2012.02.011 10.3109/1061186X.2013.860982 10.1016/j.nano.2018.11.017 10.1038/nbt1389 10.1002/hep.24758 10.1242/dmm.015784 10.1016/0003-2697(88)90412-5 10.1002/path.4013 10.1016/j.jconrel.2015.10.043 10.1111/hepr.12599 10.1016/j.jhep.2015.10.030 10.1016/S0002-9440(10)63472-4 10.1111/j.1365-2818.2006.01706.x 10.1002/hep.26181 10.1080/17460441.2017.1297416 10.1038/s41467-018-03560-x 10.1007/s13346-014-0210-2 10.1038/mt.2010.85 10.1002/hep.26211 10.1016/j.nano.2012.05.019 10.1039/C6RA18297F 10.1517/14712598.1.6.923 10.1002/hep.1840070610 10.1016/j.biomaterials.2011.01.021 10.1016/j.bbamem.2006.03.017 10.1016/j.jconrel.2014.03.028 10.1016/S0005-2736(98)00077-7 10.1039/C9NR02004G 10.1016/j.nano.2016.12.014 10.1128/JVI.01902-09 10.1016/j.jconrel.2012.03.020 10.1021/mp400038r 10.1054/bjoc.1999.1232 10.1016/S0140-6736(14)61838-9 |
| ContentType | Journal Article |
| Copyright | 2019, Witzigmann et al. COPYRIGHT 2019 eLife Science Publications, Ltd. 2019, Witzigmann et al. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019, Witzigmann et al 2019 Witzigmann et al |
| Copyright_xml | – notice: 2019, Witzigmann et al. – notice: COPYRIGHT 2019 eLife Science Publications, Ltd. – notice: 2019, Witzigmann et al. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019, Witzigmann et al 2019 Witzigmann et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7X7 7XB 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.7554/eLife.42276 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2050-084X |
| ExternalDocumentID | oai_doaj_org_article_06772f8c9ffb44f5b5c021716f8aad26 PMC6682401 A596834108 31333191 10_7554_eLife_42276 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States Heidelberg Germany Basel Switzerland Switzerland Germany |
| GeographicLocations_xml | – name: United States – name: Heidelberg Germany – name: Switzerland – name: Germany – name: Basel Switzerland |
| GrantInformation_xml | – fundername: German Center for Infection Research grantid: 5.704 – fundername: Deutsches Zentrum für Infektionsforschung grantid: 5.807 – fundername: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung grantid: 173057 – fundername: Deutsche Forschungsgemeinschaft grantid: 209091148 – fundername: Novartis grantid: Novartis University Basel Excellence Scholarship for Life Sciences – fundername: German Center for Infection Research grantid: 5.807 – fundername: Deutsches Zentrum für Infektionsforschung grantid: 5.704 – fundername: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung grantid: 174975 – fundername: Swiss National Science Foundation grantid: 174975 – fundername: Swiss National Science Foundation grantid: 173057 – fundername: ; – fundername: ; grantid: Novartis University Basel Excellence Scholarship for Life Sciences – fundername: ; grantid: 209091148 – fundername: ; grantid: FAG Basel – fundername: ; grantid: 173057 – fundername: ; grantid: 5.807 – fundername: ; grantid: 5.704 – fundername: ; grantid: 174975 |
| GroupedDBID | 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAKDD AAYXX ABUWG ACGFO ACGOD ACPRK ADBBV ADRAZ AENEX AFFHD AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK DWQXO EMOBN FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR INH INR ISR ITC KQ8 LK8 M1P M2P M48 M7P M~E NQS OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO RHI RNS RPM UKHRP 3V. ALIPV CGR CUY CVF ECM EIF FRP NPM RHF 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c576t-7d8b2b997843f9da15e9fda7b7460dfd1fa168d56ef1bb621df1955907b7053f3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 28 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000478937700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2050-084X |
| IngestDate | Tue Oct 14 19:03:33 EDT 2025 Tue Nov 04 02:05:41 EST 2025 Thu Oct 02 10:55:28 EDT 2025 Tue Oct 07 07:07:23 EDT 2025 Tue Nov 11 10:15:22 EST 2025 Tue Nov 04 17:09:29 EST 2025 Thu Nov 13 14:17:53 EST 2025 Thu Jan 02 22:58:16 EST 2025 Sat Nov 29 06:04:03 EST 2025 Tue Nov 18 21:48:06 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | hepatocyte targeting rat liposomes hepatitis B virus nanocarriers microbiology mouse chemical biology Myrcludex B infectious disease NTCP biochemistry zebrafish |
| Language | English |
| License | http://creativecommons.org/licenses/by/4.0 2019, Witzigmann et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c576t-7d8b2b997843f9da15e9fda7b7460dfd1fa168d56ef1bb621df1955907b7053f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-1748-5676 0000-0003-0458-4579 0000-0002-8197-8558 0000-0002-3416-5570 |
| OpenAccessLink | https://doaj.org/article/06772f8c9ffb44f5b5c021716f8aad26 |
| PMID | 31333191 |
| PQID | 2282978774 |
| PQPubID | 2045579 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_06772f8c9ffb44f5b5c021716f8aad26 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6682401 proquest_miscellaneous_2268573690 proquest_journals_2282978774 gale_infotracmisc_A596834108 gale_infotracacademiconefile_A596834108 gale_incontextgauss_ISR_A596834108 pubmed_primary_31333191 crossref_citationtrail_10_7554_eLife_42276 crossref_primary_10_7554_eLife_42276 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-07-23 |
| PublicationDateYYYYMMDD | 2019-07-23 |
| PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-23 day: 23 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Cambridge |
| PublicationTitle | eLife |
| PublicationTitleAlternate | Elife |
| PublicationYear | 2019 |
| Publisher | eLife Science Publications, Ltd eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
| Publisher_xml | – name: eLife Science Publications, Ltd – name: eLife Sciences Publications Ltd – name: eLife Sciences Publications, Ltd |
| References | Sieber (bib53) 2019; 17 Harrington (bib18) 2000; 83 He (bib19) 2012; 227 Uhl (bib57) 2017; 108 Veinotte (bib60) 2014; 7 Schieck (bib47) 2013; 58 Somiya (bib54) 2015; 212 Barpe (bib5) 2010; 41 Lempp (bib26) 2016; 64 Lunov (bib30) 2011; 5 Kulkarni (bib24) 2018; 12 Park (bib39) 2017; 264 Shan (bib49) 2015; 5 Brown (bib11) 2017; 12 Mayer (bib33) 1990; 1025 Campbell (bib12) 2018; 12 Poelstra (bib41) 2012; 161 Lütgehetmann (bib31) 2012; 55 Asabe (bib3) 2009; 83 Wertman (bib64) 2016; 916 Lin (bib28) 2017; 27 Einfalt (bib15) 2018; 9 Rothkopf (bib43) 2005; 1668 Braet (bib10) 2002; 1 Barenholz (bib4) 2012; 160 Witzigmann (bib71) 2016; 46 Urban (bib58) 2014; 147 Akinc (bib1) 2009; 17 Glebe (bib17) 2007; 13 Karmali (bib21) 2011; 8 Somiya (bib55) 2016; 497 Ishiwata (bib20) 2000; 69 Akinc (bib2) 2010; 18 Ni (bib38) 2014; 146 Reddy (bib42) 2011; 55 Bogomolov (bib8) 2016; 65 Witzigmann (bib69) 2015; 7 Schulze (bib48) 2010; 84 Verrier (bib61) 2016; 63 Müller (bib37) 2013; 10 van der Geest (bib59) 2015; 220 Barrett (bib6) 2014; 183 Witzigmann (bib68) 2015; 5 Kulkarni (bib25) 2019; 11 Liu (bib29) 2016; 22 Meier (bib34) 2013; 58 Wisse (bib67) 2008; 15 Mühlfeld (bib36) 2003; 163 Witzigmann (bib70) 2016; 6 Bolte (bib9) 2006; 224 Sauer (bib45) 2006; 1758 Evensen (bib16) 2016; 8 Detampel (bib14) 2014; 22 Schieck (bib46) 2010; 15 Yan (bib73) 2012; 1 Milla (bib35) 2012; 13 Sahay (bib44) 2013; 31 Zhang (bib76) 2015; 7 Kulkarni (bib23) 2017; 13 Wagner (bib62) 2010; 31 Maurer (bib32) 2001; 1 Sieber (bib51) 2017; 264 Sieber (bib52) 2019 Yin (bib74) 2018; 12 Xiao (bib72) 2011; 32 Kettiger (bib22) 2013; 8 Webb (bib63) 1998; 1372 Zhang (bib75) 2014; 35 Petersen (bib40) 2008; 26 Shih (bib50) 2017; 80 Chen (bib13) 1988; 172 Steffan (bib56) 1987; 7 Wischnjow (bib66) 2016; 27 Lin (bib27) 2013; 9 Blank (bib7) 2016; 65 Williams (bib65) 2014; 384 |
| References_xml | – year: 2019 ident: bib52 article-title: Zebrafish as a preclinical in vivo screening model for nanomedicines publication-title: Advanced Drug Delivery Reviews doi: 10.1016/j.addr.2019.01.001 – volume: 83 start-page: 9652 year: 2009 ident: bib3 article-title: The size of the viral inoculum contributes to the outcome of hepatitis B virus infection publication-title: Journal of Virology doi: 10.1128/JVI.00867-09 – volume: 108 start-page: 111 year: 2017 ident: bib57 article-title: Oral delivery of vancomycin by tetraether lipid liposomes publication-title: European Journal of Pharmaceutical Sciences doi: 10.1016/j.ejps.2017.07.013 – volume: 65 start-page: 490 year: 2016 ident: bib8 article-title: Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase ib/IIa study publication-title: Journal of Hepatology doi: 10.1016/j.jhep.2016.04.016 – volume: 7 start-page: 9298 year: 2015 ident: bib76 article-title: A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus publication-title: Nanoscale doi: 10.1039/C4NR04730C – volume: 212 start-page: 10 year: 2015 ident: bib54 article-title: Intracellular trafficking of bio-nanocapsule-liposome complex: identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2015.06.012 – volume: 69 start-page: 139 year: 2000 ident: bib20 article-title: Characteristics and biodistribution of cationic liposomes and their DNA complexes publication-title: Journal of Controlled Release doi: 10.1016/S0168-3659(00)00293-5 – volume: 1668 start-page: 10 year: 2005 ident: bib43 article-title: Uptake of phosphatidylserine-containing liposomes by liver sinusoidal endothelial cells in the serum-free perfused rat liver publication-title: Biochimica Et Biophysica Acta (BBA) - Biomembranes doi: 10.1016/j.bbamem.2004.10.013 – volume: 22 start-page: 8489 year: 2016 ident: bib29 article-title: Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule publication-title: World Journal of Gastroenterology doi: 10.3748/wjg.v22.i38.8489 – volume: 5 start-page: 74320 year: 2015 ident: bib68 article-title: Formation of lipid and polymer based gold nanohybrids using a nanoreactor approach publication-title: RSC Advances doi: 10.1039/C5RA13967H – volume: 15 start-page: 1193 year: 2008 ident: bib67 article-title: The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer publication-title: Gene Therapy doi: 10.1038/gt.2008.60 – volume: 31 start-page: 653 year: 2013 ident: bib44 article-title: Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling publication-title: Nature Biotechnology doi: 10.1038/nbt.2614 – volume: 8 start-page: 862 year: 2016 ident: bib16 article-title: Zebrafish as a model system for characterization of nanoparticles against Cancer publication-title: Nanoscale doi: 10.1039/C5NR07289A – volume: 41 start-page: 458 year: 2010 ident: bib5 article-title: Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast Cancer and simulation of dose adjustment by different indexes of body mass publication-title: European Journal of Pharmaceutical Sciences doi: 10.1016/j.ejps.2010.07.015 – volume: 13 start-page: 22 year: 2007 ident: bib17 article-title: Viral and cellular determinants involved in hepadnaviral entry publication-title: World Journal of Gastroenterology doi: 10.3748/wjg.v13.i1.22 – volume: 147 start-page: 48 year: 2014 ident: bib58 article-title: Strategies to inhibit entry of HBV and HDV into hepatocytes publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.04.030 – volume: 12 start-page: 2088 year: 2018 ident: bib74 article-title: Toward understanding in vivo sequestration of nanoparticles at the molecular level publication-title: ACS Nano doi: 10.1021/acsnano.8b00141 – volume: 17 start-page: 872 year: 2009 ident: bib1 article-title: Development of lipidoid-siRNA formulations for systemic delivery to the liver publication-title: Molecular Therapy doi: 10.1038/mt.2009.36 – volume: 12 start-page: 2138 year: 2018 ident: bib12 article-title: Directing nanoparticle biodistribution through evasion and exploitation of Stab2-Dependent nanoparticle uptake publication-title: ACS Nano doi: 10.1021/acsnano.7b06995 – volume: 264 start-page: 342 year: 2017 ident: bib39 article-title: Cover story: zebrafish as a screening tool for the systemic circulation of nanoparticles publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2017.09.037 – volume: 31 start-page: 7567 year: 2010 ident: bib62 article-title: The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate Cancer xenografts publication-title: Biomaterials doi: 10.1016/j.biomaterials.2010.06.031 – volume: 65 start-page: 483 year: 2016 ident: bib7 article-title: First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B publication-title: Journal of Hepatology doi: 10.1016/j.jhep.2016.04.013 – volume: 916 start-page: 289 year: 2016 ident: bib64 article-title: The zebrafish xenograft platform: evolution of a novel Cancer model and preclinical screening tool publication-title: Advances in Experimental Medicine and Biology doi: 10.1007/978-3-319-30654-4_13 – volume: 55 start-page: 1461 year: 2011 ident: bib42 article-title: Nanotechnology for therapy and imaging of liver diseases publication-title: Journal of Hepatology doi: 10.1016/j.jhep.2011.05.039 – volume: 8 start-page: 3255 year: 2013 ident: bib22 article-title: Engineered nanomaterial uptake and tissue distribution: from cell to organism publication-title: International Journal of Nanomedicine doi: 10.2147/IJN.S49770 – volume: 12 start-page: 4787 year: 2018 ident: bib24 article-title: On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA publication-title: ACS Nano doi: 10.1021/acsnano.8b01516 – volume: 497 start-page: 23 year: 2016 ident: bib55 article-title: Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan publication-title: Virology doi: 10.1016/j.virol.2016.06.024 – volume: 1 year: 2012 ident: bib73 article-title: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus publication-title: eLife doi: 10.7554/eLife.00049 – volume: 15 start-page: 4773 year: 2010 ident: bib46 article-title: Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitor publication-title: Molecules doi: 10.3390/molecules15074773 – volume: 80 start-page: 766 year: 2017 ident: bib50 article-title: SPECT imaging evaluation of 111indium-chelated cetuximab for diagnosing EGFR-positive tumor in an HCT-15-induced colorectal xenograft publication-title: Journal of the Chinese Medical Association doi: 10.1016/j.jcma.2017.02.010 – volume: 27 start-page: 1701418 year: 2017 ident: bib28 article-title: Robust red organic nanoparticles for in vivo fluorescence imaging of Cancer cell progression in xenografted zebrafish publication-title: Advanced Functional Materials doi: 10.1002/adfm.201701418 – volume: 13 start-page: 105 year: 2012 ident: bib35 article-title: PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery publication-title: Current Drug Metabolism doi: 10.2174/138920012798356934 – volume: 27 start-page: 1050 year: 2016 ident: bib66 article-title: Renal targeting: peptide-based drug delivery to proximal tubule cells publication-title: Bioconjugate Chemistry doi: 10.1021/acs.bioconjchem.6b00057 – volume: 1025 start-page: 143 year: 1990 ident: bib33 article-title: Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients publication-title: Biochimica Et Biophysica Acta (BBA) - Biomembranes doi: 10.1016/0005-2736(90)90091-2 – volume: 63 start-page: 35 year: 2016 ident: bib61 article-title: A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses publication-title: Hepatology doi: 10.1002/hep.28013 – volume: 146 start-page: 1070 year: 2014 ident: bib38 article-title: Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.12.024 – volume: 8 start-page: 343 year: 2011 ident: bib21 article-title: Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems publication-title: Expert Opinion on Drug Delivery doi: 10.1517/17425247.2011.554818 – volume: 7 start-page: 10446 year: 2015 ident: bib69 article-title: Biocompatible polymer-Peptide hybrid-based DNA nanoparticles for gene delivery publication-title: ACS Applied Materials & Interfaces doi: 10.1021/acsami.5b01684 – volume: 1 year: 2002 ident: bib10 article-title: Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review publication-title: Comparative Hepatology doi: 10.1186/1476-5926-1-1 – volume: 5 start-page: 1657 year: 2011 ident: bib30 article-title: Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line publication-title: ACS Nano doi: 10.1021/nn2000756 – volume: 35 start-page: 6130 year: 2014 ident: bib75 article-title: Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.04.037 – volume: 264 start-page: 180 year: 2017 ident: bib51 article-title: Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2017.08.023 – volume: 161 start-page: 188 year: 2012 ident: bib41 article-title: Drug targeting to the diseased liver publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2012.02.011 – volume: 22 start-page: 232 year: 2014 ident: bib14 article-title: Hepatocyte targeting using pegylated asialofetuin-conjugated liposomes publication-title: Journal of Drug Targeting doi: 10.3109/1061186X.2013.860982 – volume: 17 start-page: 82 year: 2019 ident: bib53 article-title: Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo publication-title: Nanomedicine: Nanotechnology, Biology and Medicine doi: 10.1016/j.nano.2018.11.017 – volume: 26 start-page: 335 year: 2008 ident: bib40 article-title: Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein publication-title: Nature Biotechnology doi: 10.1038/nbt1389 – volume: 55 start-page: 685 year: 2012 ident: bib31 article-title: Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation publication-title: Hepatology doi: 10.1002/hep.24758 – volume: 7 start-page: 745 year: 2014 ident: bib60 article-title: Hooking the big one: the potential of zebrafish xenotransplantation to reform Cancer drug screening in the genomic era publication-title: Disease Models & Mechanisms doi: 10.1242/dmm.015784 – volume: 172 start-page: 61 year: 1988 ident: bib13 article-title: Mechanism of fluorescence concentration quenching of carboxyfluorescein in liposomes: energy transfer to nonfluorescent dimers publication-title: Analytical Biochemistry doi: 10.1016/0003-2697(88)90412-5 – volume: 227 start-page: 431 year: 2012 ident: bib19 article-title: Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model publication-title: The Journal of Pathology doi: 10.1002/path.4013 – volume: 220 start-page: 239 year: 2015 ident: bib59 article-title: Comparison of three remote radiolabelling methods for long-circulating liposomes publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2015.10.043 – volume: 46 start-page: 686 year: 2016 ident: bib71 article-title: Variable asialoglycoprotein receptor 1 expression in liver disease: implications for therapeutic intervention publication-title: Hepatology Research doi: 10.1111/hepr.12599 – volume: 64 start-page: 556 year: 2016 ident: bib26 article-title: Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor publication-title: Journal of Hepatology doi: 10.1016/j.jhep.2015.10.030 – volume: 163 start-page: 1127 year: 2003 ident: bib36 article-title: Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis publication-title: The American Journal of Pathology doi: 10.1016/S0002-9440(10)63472-4 – volume: 224 start-page: 213 year: 2006 ident: bib9 article-title: A guided tour into subcellular colocalization analysis in light microscopy publication-title: Journal of Microscopy doi: 10.1111/j.1365-2818.2006.01706.x – volume: 58 start-page: 31 year: 2013 ident: bib34 article-title: Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes publication-title: Hepatology doi: 10.1002/hep.26181 – volume: 12 start-page: 379 year: 2017 ident: bib11 article-title: Zebrafish xenograft models of Cancer and metastasis for drug discovery publication-title: Expert Opinion on Drug Discovery doi: 10.1080/17460441.2017.1297416 – volume: 9 year: 2018 ident: bib15 article-title: Biomimetic artificial organelles with in vitro and in vivo activity triggered by reduction in microenvironment publication-title: Nature Communications doi: 10.1038/s41467-018-03560-x – volume: 5 start-page: 15 year: 2015 ident: bib49 article-title: RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells publication-title: Drug Delivery and Translational Research doi: 10.1007/s13346-014-0210-2 – volume: 18 start-page: 1357 year: 2010 ident: bib2 article-title: Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms publication-title: Molecular Therapy doi: 10.1038/mt.2010.85 – volume: 58 start-page: 43 year: 2013 ident: bib47 article-title: Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts publication-title: Hepatology doi: 10.1002/hep.26211 – volume: 9 start-page: 233 year: 2013 ident: bib27 article-title: Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA publication-title: Nanomedicine: Nanotechnology, Biology and Medicine doi: 10.1016/j.nano.2012.05.019 – volume: 6 start-page: 97636 year: 2016 ident: bib70 article-title: Isolation of multiantennary N-glycans from glycoproteins for hepatocyte specific targeting via the asialoglycoprotein receptor publication-title: RSC Advances doi: 10.1039/C6RA18297F – volume: 1 start-page: 923 year: 2001 ident: bib32 article-title: Developments in liposomal drug delivery systems publication-title: Expert Opinion on Biological Therapy doi: 10.1517/14712598.1.6.923 – volume: 7 start-page: 1230 year: 1987 ident: bib56 article-title: Increase in the number of fenestrae in mouse endothelial liver cells by altering the cytoskeleton with cytochalasin B publication-title: Hepatology doi: 10.1002/hep.1840070610 – volume: 32 start-page: 3435 year: 2011 ident: bib72 article-title: The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles publication-title: Biomaterials doi: 10.1016/j.biomaterials.2011.01.021 – volume: 1758 start-page: 552 year: 2006 ident: bib45 article-title: Dipalmitoylation of a cellular uptake-mediating apolipoprotein E-derived peptide as a promising modification for stable anchorage in liposomal drug carriers publication-title: Biochimica Et Biophysica Acta (BBA) - Biomembranes doi: 10.1016/j.bbamem.2006.03.017 – volume: 183 start-page: 124 year: 2014 ident: bib6 article-title: Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2014.03.028 – volume: 1372 start-page: 272 year: 1998 ident: bib63 article-title: Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine publication-title: Biochimica Et Biophysica Acta (BBA) - Biomembranes doi: 10.1016/S0005-2736(98)00077-7 – volume: 11 start-page: 9023 year: 2019 ident: bib25 article-title: Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads publication-title: Nanoscale doi: 10.1039/C9NR02004G – volume: 13 start-page: 1377 year: 2017 ident: bib23 article-title: Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA publication-title: Nanomedicine: Nanotechnology, Biology and Medicine doi: 10.1016/j.nano.2016.12.014 – volume: 84 start-page: 1989 year: 2010 ident: bib48 article-title: Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction publication-title: Journal of Virology doi: 10.1128/JVI.01902-09 – volume: 160 start-page: 117 year: 2012 ident: bib4 article-title: Doxil--the first FDA-approved nano-drug: lessons learned publication-title: Journal of Controlled Release doi: 10.1016/j.jconrel.2012.03.020 – volume: 10 start-page: 2230 year: 2013 ident: bib37 article-title: Liver imaging with a novel hepatitis B surface protein derived SPECT-tracer publication-title: Molecular Pharmaceutics doi: 10.1021/mp400038r – volume: 83 start-page: 232 year: 2000 ident: bib18 article-title: Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies publication-title: British Journal of Cancer doi: 10.1054/bjoc.1999.1232 – volume: 384 start-page: 1953 year: 2014 ident: bib65 article-title: Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis publication-title: The Lancet doi: 10.1016/S0140-6736(14)61838-9 |
| SSID | ssj0000748819 |
| Score | 2.3624003 |
| Snippet | Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Animals Biochemistry and Chemical Biology Drug Carriers - administration & dosage Drug delivery Drug delivery systems Drug Delivery Systems - methods Drug dosages Fluorescence Fluorescence microscopy Hepatitis Hepatitis B Hepatitis B Surface Antigens - administration & dosage Hepatitis B virus hepatocyte targeting Hepatocytes Internalization Ligands Lipids liposomes Liposomes - administration & dosage Liver Liver - diagnostic imaging Liver diseases Microbiology and Infectious Disease Microscopy Myrcludex B nanocarriers Nanoparticles NTCP Optimization Organic Anion Transporters, Sodium-Dependent - administration & dosage Organic Anion Transporters, Sodium-Dependent - pharmacokinetics Peptides Pharmaceutical sciences Pharmacokinetics Physicochemical properties Polypeptides Production processes Proteins Radionuclide Imaging Scintigraphy Sodium Statistical analysis Symporters - administration & dosage Symporters - pharmacokinetics Technology application Variance analysis Veins & arteries Viral envelope proteins Zebrafish |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9UwEA66Kvji_VJdpcqCINRtkzZNn2QVFwVZFy-wbyHX3cLZ9njao-y_d6bNqacovvjaTC_JTOaSznxDyJ5zWICZuoRTryFA0aAHuc8TXlQOxIVZX9ih2UR5dCROTqrjcODWhbTKjU4cFLVtDZ6R71P85QfSVeavl98T7BqFf1dDC43L5AqiJLAhde94OmMB8yjA4o1leSUYzn33sfbuVU4pYoxsGaIBr_9PrbxlluYpk1s26PDm_379LXIjeJ_xwSgut8kl19wh18Z-lBd3yc9PoEDOQ2Vmoi8SO-R3xK2Pz8Bs9W2_ape1iRf1srZxoxqIuENiXTymlIMhjMGljLvW1uvzpFdrbMkF4XPvYgO3ByR1JFu2C4iB4YXW3SPfDt99ffs-CZ0ZEgPxSZ-UVmiqK5hRznxlVVa4yltV6jLnqfU28yrjwhbc-UxrTjPrM4S6S4ECdr1n98lO0zbuIYmpKa3X1jFVmVwgAJ1RBfXUmMIIr1hEXm7YJE2ALcfuGQsJ4QvyVA48lQNPI7I3ES9HtI6_k71Bfk8kCLE9XGhXpzKsm0RoPeqFqbzXee4LXRiM3zLuhVKWwkOeo7RIBNFoMEvnVK27Tn748lkeFBUX4B6kIiIvApHHNTYqFD3A3BF3a0a5O6OEXW7mwxvBkkHLdPK3VEXk2TSMd2LmXOPaNdJwUZSMV2lEHowyPM2bZYyBCs4iUs6ke7Yw85GmPhswyDkX4Atmj_79WY_JdXAwsUouoWyX7PSrtXtCrpoffd2tng6b9RdLxE7a priority: 102 providerName: ProQuest |
| Title | Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31333191 https://www.proquest.com/docview/2282978774 https://www.proquest.com/docview/2268573690 https://pubmed.ncbi.nlm.nih.gov/PMC6682401 https://doaj.org/article/06772f8c9ffb44f5b5c021716f8aad26 |
| Volume | 8 |
| WOSCitedRecordID | wos000478937700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: M7P dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: 7X7 dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: BENPR dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: PIMPY dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: M2P dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-0VfCl-G1qPaIUBCH2dpPsbh5babFgz6MqnE_LZj9s4Jocdzml_70zm_S4oOCLL_uQnZBkZnY-yMxvCDl0Dhswxy7hzJeQoJRgB7nPEp4XDtQltT63YdiEmEzkbFZMt0Z9YU1YBw_cMe4IEc6Yl6bwvswyn5e5wTCaci-1tiyAbUPUs5VMBRssQDFp0TXkCXCZR-5T5d37jDFEF9lyQQGp_097vOWQhsWSW97n7CHZ68PG-Lh73Ufkjqsfk_vdIMmbJ-TXZzj5131LZVLeJDYUZsSNj6_A37RNu2wWlYnn1aKyca1rSJX7iri4qwUHDxZDLBivGlutr5NWr3GWFuS9rYsN3N5DoCPZoplD8goPtO4p-XZ2-vXDx6QfqZAYSCzaRFhZsrKA1DFLfWE1zV3hrRalyPjYeku9plzanDtPy5Izaj1FjLoxUMBx9ekzslM3tXtBYmaE9aV1qS5MJhE5zuiceWZMbqTXaUTe3XJZmR5vHMdezBXkHSgSFUSigkgicrghXnQwG38nO0FxbUgQGztcAI1RPd_UvzQmIm9Q2ArRL2osr_mh16uVOv9yqY7zgkvw62MZkbc9kUceG913K8C3I2DWgPJgQAnH0wy3b3VK9eZhpRj-vwZTKbKIvN5s451Y8la7Zo00XOYi5cU4Is87Fdx8d0rTFGwnjYgYKOeAMcOduroK4OGcSwji6P7_4ORL8gDiR2yCS1h6QHba5dq9IvfMz7ZaLUfkrpiJsMoR2T05nUwvR-GUwnrBprgKWHen5xfT778B-NJHuw |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwELZKAcEL9xEoEFARElLoxkkc5wGhclRddSkVFKlvxvHRRtomYZOl2j_Fb2Qmx7IRiLc-8LqeOGvn8xzJzDeEbBqDBZgj4zFqUwhQUtCDzIYeixIDcAm0jXTTbCLe3-dHR8nBGvnZ18JgWmWvExtFrQuF78i3KH7yA3TF4Zvyu4ddo_Drat9Co4XFnlmcQchWvR6_h-f7nNKdD4fvdr2uq4CnwLeuvVjzlKYJzBUGNtHSj0xitYzTOGQjbbVvpc-4jpixfpoy6mvrI03bCCQAsTaAeS-Qi-BGUN6kCh4s3-mAOeZgYdsywBgM9ZaZZNa8CilFTpMVw9f0B_jTCqyYwWGK5orN27n-v-3WDXKt867d7fY43CRrJr9FLrf9Nhe3ydknUJCnXeWply483eSvuIV1T8As10U9K8pMudOszLSby7wo-8RBt02ZB0PvgsvsVoXO5qdeLefYcqyYgsfuKri8Y4pHsbKYQowPN9TmDvl6Lqu-S9bzIjf3iUtVrG2qTSATFXIk2FMyopYqFSluZeCQlz0shOpo2bE7yFRAeIYYEg2GRIMhh2wuhcuWjeTvYm8RX0sRpBBvfihmx6LbN4HUgdRylVibhqGN0khhfOozy6XUFCZ5hugUSBKSYxbSsZxXlRh_-Sy2o4RxcH9G3CEvOiGLe6xkV9QBa0desYHkxkAStJgaDvdAFp0WrcRvFDvk6XIYr8TMwNwUc5RhPIoDlowccq89M8t1B34QgInxHRIPTtNgY4YjeXbScKwzxsHX9R_8-289IVd2Dz9OxGS8v_eQXAVnGisCPRpskPV6NjePyCX1o86q2eNGUbjk23mftV9bvqxt |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9NAEF6VcogX7sNQwKAiJCSTeG2v1w8IFUpE1CpEHFLflvUeraXUNrFDlb_Gr2PGdkIsEG994DU7XmfX385hz3xDyK4xWIA5NB6jNoUAJQU9yGzosSgxAJdA20g3zSbiyYQfHSXTLfJzVQuDaZUrndgoal0ofEc-oPjJD9AVhwPbpUVM90dvyu8edpDCL62rdhotRA7M8gzCt-r1eB-e9XNKR--_vPvgdR0GPAV-du3Fmqc0TWDeMLCJln5kEqtlnMYhG2qrfSt9xnXEjPXTlFFfWx8p24YgAei1Acx7gVyMkbS8SRucrt_vgGnmYG3bksAYjPbAHGbWvAopRX6TDSPY9Ar40yJsmMR-uuaG_Rtd_5937ga51nnd7l57TG6SLZPfIpfbPpzL2-TsIyjO064i1UuXnm7yWtzCuidgruuinhdlptxZVmbazWVelKuEQrdNpQcHwAVX2q0KnS1OvVousBVZMQNP3lVweccgj2JlMYPYH26ozR3y9VxWfZds50Vu7hOXqljbVJtAJirkSLynZEQtVSpS3MrAIS9XEBGqo2vHriEzAWEb4kk0eBINnhyyuxYuW5aSv4u9RaytRZBavPmhmB-Lbt8EUgpSy1VibRqGNkojhXGrzyyXUlOY5BkiVSB5SI5gOpaLqhLjz5_EXpQwDm7RkDvkRSdkcY-V7Io9YO3IN9aT3OlJgnZT_eEVqEWnXSvxG9EOeboexisxYzA3xQJlGI_igCVDh9xrz8963YEfBGB6fIfEvZPV25j-SJ6dNNzrjHHwgf0H__5bT8gVOGLicDw5eEiugo-NhYIeDXbIdj1fmEfkkvpRZ9X8caMzXPLtvI_aL8XvtSo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimization-by-design+of+hepatotropic+lipid+nanoparticles+targeting+the+sodium-taurocholate+cotransporting+polypeptide&rft.jtitle=eLife&rft.au=Witzigmann%2C+Dominik&rft.au=Uhl%2C+Philipp&rft.au=Sieber%2C+Sandro&rft.au=Kaufman%2C+Christina&rft.date=2019-07-23&rft.pub=eLife+Science+Publications%2C+Ltd&rft.issn=2050-084X&rft.eissn=2050-084X&rft.volume=8&rft_id=info:doi/10.7554%2FeLife.42276&rft.externalDocID=A596834108 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-084X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-084X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-084X&client=summon |